PO.CL05.13 · 临床研究
Vaccines and Other Immunomodulatory Agents
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- 6707 6707 Developing oncolytic measles virus expressing MG53 for the treatment of lung cancer Zhongguang Li, Cheng Chih Hsu, Fei Jiang, Matthew Bu, Ellica Leong, Umme Lubaba, Xuefeng Liu, Jianrong Li, Haichang Li
-
-
- 6710 6710 Development of T cell activating nucleic acid fusion vaccine to prevent metastatic uveal melanoma establishment Vitali Alexeev, Mizue Terai, Sergei Koshkin, Takami Sato
-
- 6712 6712 Promoting improved agnostic cross presentation of tumor antigens with an oncolytic adenovirus expressing bispecific macrophage engagers Ahmet Hazini, Margarida Rei, Natanya Cartwright, Ricardo A. Fernandes, Kerry Fisher, Len Seymour
-
-
- 6715 6715 Safety, tolerability, and early immune responses in the safety run-in of an HER2 multi-epitope vaccine combined with T-DM1 in residual HER2-positive breast cancer Saranya Chumsri, Sharmila Giri, Andy J. Ness, David W. Hillman, Nadine Norton, Davitte Cogen, Brian M. Necela, Aziza Nassar, Donald W. Northfelt, Pooja Advani, Rohit Rao, Alvaro Mareno-Aspitia, Brenda Ernst, Kathryn J. Ruddy, Matthew P. Goetz, Keith L. Knutson
-
-
-
